Positive Outcomes Influence the Rate and Time to Publication, but Not the Impact Factor of Publications of Clinical Trial Results
TLDR
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results, however, no differences have been found in terms of impact factor.Abstract:
Objectives
Publication bias may affect the validity of evidence based medical decisions. The aim of this study is to assess whether research outcomes affect the dissemination of clinical trial findings, in terms of rate, time to publication, and impact factor of journal publications.
Methods and Findings
All drug-evaluating clinical trials submitted to and approved by a general hospital ethics committee between 1997 and 2004 were prospectively followed to analyze their fate and publication. Published articles were identified by searching Pubmed and other electronic databases. Clinical study final reports submitted to the ethics committee, final reports synopses available online and meeting abstracts were also considered as sources of study results. Study outcomes were classified as positive (when statistical significance favoring experimental drug was achieved), negative (when no statistical significance was achieved or it favored control drug) and descriptive (for non-controlled studies). Time to publication was defined as time from study closure to publication. A survival analysis was performed using a Cox regression model to analyze time to publication. Journal impact factors of identified publications were recorded. Publication rate was 48·4% (380/785). Study results were identified for 68·9% of all completed clinical trials (541/785). Publication rate was 84·9% (180/212) for studies with results classified as positive and 68·9% (128/186) for studies with results classified as negative (p<0·001). Median time to publication was 2·09 years (IC95 1·61–2·56) for studies with results classified as positive and 3·21 years (IC95 2·69–3·70) for studies with results classified as negative (hazard ratio 1·99 (IC95 1·55–2·55). No differences were found in publication impact factor between positive (median 6·308, interquartile range: 3·141–28·409) and negative result studies (median 8·266, interquartile range: 4·135–17·157).
Conclusions
Clinical trials with positive outcomes have significantly higher rates and shorter times to publication than those with negative results. However, no differences have been found in terms of impact factor.read more
Citations
More filters
Posted ContentDOI
Free water in white matter differentiates MCI and AD from control subjects
Matthieu Dumont,Maggie Roy,Pierre-Marc Jodoin,Felix C. Morency,Jean-Christophe Houde,Zhiyong Xie,Cici Bauer,Tarek A. Samad,Koene R. A. Van Dijk,James A. Goodman,Maxime Descoteaux +10 more
TL;DR: A simple FW processing pipeline is developed that uses a safe white matter (WM) mask without gray matter (GM)/CSF partial volume contamination (WMsafe) near ventricles and sulci and demonstrates that the FW measures are not just a byproduct of WMHs.
Journal ArticleDOI
Prenatal Exposure to Polychlorinated Biphenyls and Their Hydroxylated Metabolites is Associated with Neurological Functioning in 3-Month-Old Infants
TL;DR: Higher prenatal exposure to Dutch background PCB levels is associated with better neurological functioning in 3-month-old infants and Prenatal exposure to 4-OH-PCB-107 is associated in boys less optimal neurological functioning.
Journal ArticleDOI
Down syndrome cell adhesion molecule 1: testing for a role in insect immunity, behaviour and reproduction.
Robert Peuß,Kristina U. Wensing,Luisa Woestmann,Hendrik Eggert,Barbara Milutinović,Marlene Gunda Ursel Sroka,Jörn P. Scharsack,Joachim Kurtz,Sophie A. O. Armitage +8 more
TL;DR: It is suggested that Dscam1 does not always play a straightforward role in immunity, but strongly influences behaviour and fecundity, and is a step towards understanding more about the role of this intriguing gene from different phenotypic perspectives.
Journal ArticleDOI
Single-Cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer Subtype
Marta Prieto-Vila,Wataru Usuba,Ryou-u Takahashi,Iwao Shimomura,Hideo Sasaki,Takahiro Ochiya,Yusuke Yamamoto +6 more
TL;DR: Interestingly, a small number of cells in the parental population exhibited a gene expression profile similar to that of the drug-resistant cells, indicating that the untreated parental cells already contained a rare subpopulation of stem-like cells with an inherent predisposition towards docetaxel resistance.
Posted ContentDOI
Telomeres as integrative markers of exposure to stress and adversity: A systematic review and meta-analysis
TL;DR: There was a weak association between telomere variables and exposures, and significant associations were found separately for physical diseases, environmental hazards, nutrition, psychiatric illness, smoking, physical activity, psychosocial and socioeconomic exposures.
References
More filters
Journal ArticleDOI
Pharmacological interventions for somatoform disorders in adults.
Maria Kleinstäuber,Michael Witthöft,Andrés Steffanowski,Harm W.J. van Marwijk,Wolfgang Hiller,Michael J. Lambert +5 more
TL;DR: A systematic review and meta-analysis of placebo-controlled studies examined the efficacy and tolerability of different types of antidepressants, the combination of an antidepressant and an antipsychotic, antipsychotics alone, or natural products in adults with somatoform disorders in adults to improve optimal treatment decisions.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement.
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and should provide the reader with the ability to make informed judgments regarding the internal and external validity of the trial.
Journal ArticleDOI
Publication bias in clinical research
TL;DR: The presence of publication bias in a cohort of clinical research studies is confirmed and it is suggested that conclusions based only on a review of published data should be interpreted cautiously, especially for observational studies.
Journal ArticleDOI
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
Colin B. Begg,Mildred K. Cho,Susan Eastwood,Richard Horton,David Moher,Ingram Olkin,Roy M. Pitkin,Drummond Rennie,Kenneth F. Schulz,David L. Simel,Donna F. Stroup +10 more
TL;DR: For RCTs to ultimately benefit patients, the published report should be of the highest possible standard and accurate and complete reporting is needed.
Journal ArticleDOI
Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.
TL;DR: The reporting of trial outcomes is not only frequently incomplete but also biased and inconsistent with protocols and Published articles, as well as reviews that incorporate them, may therefore be unreliable and overestimate the benefits of an intervention.